The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer

Callum Hall, Patricia Muller

Research output: Contribution to journalArticlepeer-review


The p53 family of proteins has grown substantially over the last 40 years. It started with p53, then p63, p73, isoforms and mutants of these proteins. The function of p53 as a tumour suppressor has been thoroughly investigated, but the functions of all isoforms and mutants and the interplay between them are still poorly understood. Mutant p53 proteins lose p53 function, display dominant-negative (DN) activity and display gain-of-function (GOF) to varying degrees. GOF was originally attributed to mutant p53′s inhibitory function over the p53 family members p63 and p73. It has become apparent that this is not the only way in which mutant p53 operates as a large number of transcription factors that are not related to p53 are activated on mutant p53 binding. This raises the question to what extent mutant p53 binding to p63 and p73 plays a role in mutant p53 GOF. In this review, we discuss the literature around the interaction between mutant p53 and family members, including other binding partners, the functional consequences and potential therapeutics.
Original languageEnglish
JournalInternational Journal of Molecular Sciences
Publication statusPublished - 7 Dec 2019

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre


Dive into the research topics of 'The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer'. Together they form a unique fingerprint.

Cite this